Can quadruple test parameters predict SGA infants?

References

• Beta J, Bredaki FE, Calvo JR, Akolekar R, Nicolaides KH. 2011. Maternal serum-fetoprotein at 11–13 weeks’ gestation in spontaneous early preterm delivery. Fetal Diagnosis and Therapy 30:88–93.
   PubMed Web of Science ®Google Scholar
• Caniggia I, Winter J, Lye SJ, Post M. 2000. Oxygen and placental development during the first trimester: implications for the pathophysiology of pre-eclampsia. Placenta 21(Suppl A):S25–S30.
   PubMed Web of Science ®Google Scholar
• Dugoff L, Hobbins JC, Malone FD, Vidaver J, Sullivan L, Canick JA . 2005. Quad screen as a predictor of adverse pregnancy outcome. Obstetrics and Gynecology 106:260–267.
   PubMed Web of Science ®Google Scholar
• Filippi E, Staughton J, Peregrine E, Jones P, Huttly W, Peebles DM . 2011. Uterine artery Doppler and adverse pregnancy outcome in women with extreme levels of fetoplacental proteins used for Down syndrome screening. Ultrasound in Obstetrics and Gynecology 37:520–527.
   PubMed Web of Science ®Google Scholar
• Fitzgerald B, Levytska K, Kingdom B, Walker M, Baczyk D, Keating S. 2011. Villous trophoblast abnormalities in extremely preterm deliveries with elevated second trimester maternal serum hCG or inhibin-A. Placenta 32:339–345.
   PubMed Web of Science ®Google Scholar
• Gagnon A, Wilson RD, Audibert F, Allen VM, Blight C, Brock JA . 2008. Obstetrical complications associated with abnormal maternal serum markers analytes. Journal of Obstetrics and Gynaecology Canada 30:918–949.
   PubMedGoogle Scholar
• Ganapathy R, Lamont RF, Bassett P. 2007. Unexplained elevated maternal serum beta-HCG concentration and adverse pregnancy outcome. Prenatal Diagnosis 27:995–999.
   PubMed Web of Science ®Google Scholar
• Ilagan JG, Stamilio DM, Ural SH, Macones GA, Odibo AO. 2004. Abnormal multiple marker screens are associated with adverse perinatal outcomes in cases of intrauterine growth restriction. American Journal of Obstetrics and Gynecology 191:1465–1469.
   PubMed Web of Science ®Google Scholar
• Itoh Y, Suzuki Y, Yamamoto T, Kojima K, Suzumori N. 2006. Increase in serum concentrations of inhibin in early onset pre-eclampsia with intrauterine growth restriction. Journal of Obstetrics and Gynaecology Research 32:80–85.
   PubMed Web of Science ®Google Scholar
• Karsidag AY, Buyukbayrak EE, Kars B, Suyugul U, Unal O, Turan MC. 2010. The relationship between unexplained elevated serum markers in triple test, uterine artery Doppler measurements and adverse pregnancy outcome. Journal of the Pakistan Medical Association 60:181–186.
   PubMed Web of Science ®Google Scholar
• Keelan JA, Taylor R, Schellenberg JC, Groome NP, Mitchell MD, North RA. 2002. Serum activin A, inhibin A, and follistatin concentrations in preeclampsia or small for gestational age pregnancies. Obstetrics and Gynecology 99:267–274.
   PubMed Web of Science ®Google Scholar
• Kim SY, Kim SK, Lee JS, Kim IK, Lee K. 2000. The prediction of adverse pregnancy outcome using low unconjugated estriol in the second trimester of pregnancy without risk of Down's syndrome. Yonsei Medical Journal 41:226–229.
   PubMed Web of Science ®Google Scholar
• Kok JH, den Ouden AL, Verloove-Vanhorick SP, Brand R. 1998. Outcome of very preterm small for gestational age infants: the first nine years of life. British Journal of Obstetrics and Gynaecology 105:162–168.
   PubMedGoogle Scholar
• Kowalczyk TD, Cabaniss ML, Cusmano L. 1998. Association of low unconjugated estriol values in the second trimester and adverse pregnancy outcome. Obstetrics and Gynecology 91:396–400.
   PubMed Web of Science ®Google Scholar
• Lao MR, Calhoun BC, Bracero LA, Wang Y, Seybold DJ, Broce M . 2009. The ability of the quadruple test to predict adverse perinatal outcomes in a high-risk obstetric population. Journal of Medical Screening 16:55–59.
   PubMed Web of Science ®Google Scholar
• Lei ZM, Reshef E, Rao CV. 1992. The expression of human chorionic gonadotropin/luteinizing hormone receptors in human endometrial and myometrial blood vessels. Journal of Clinical Endocrinology and Metabolism 75:651–659.
   PubMed Web of Science ®Google Scholar
• Liang OD, Korff T, Eckhardt J, Rifaat J, Baal N, Herr F . 2004. Oncodevelopmental alphafetoprotein acts as a selective proangiogenic factor on endothelial cell from the fetomaternal unit. Journal of Clinical Endocrinology and Metabolism 89:1415–1422.
   PubMed Web of Science ®Google Scholar
• Lindqvist PG, Molin J. 2005. Does antenatal identification of small-for- gestational age fetuses significantly improve their outcome? Ultrasound in Obstetrics and Gynecology 25:258–264.
   PubMed Web of Science ®Google Scholar
• Minami S, Yamoto M, Nakano R. 1995. Sources of inhibin in early pregnancy. Early Pregnancy 1:62–66.
   PubMedGoogle Scholar
• Newby D, Dalgliesh G, Lyall F, Aitken DA. 2005. Alphafetoprotein and alphafetoprotein receptor expression in the normal human placenta at term. Placenta 26:190–200.
   PubMed Web of Science ®Google Scholar
• Odibo AO, Sehdev HM, Stamilio DM, Macones GA. 2006. Evaluating the threshold of abnormal second trimester multiple marker screening tests associated with intrauterine growth restriction. American Journal of Perinatology 23:363–367.
   PubMed Web of Science ®Google Scholar
• Spencer K. 2000. Second trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome. Prenatal Diagnosis 20:652–656.
   PubMed Web of Science ®Google Scholar
• Tao YX, Lei ZM, Hofmann GE, Rao CV. 1995. Human intermediate trophoblasts express chorionic gonadotropin/luteinizing hormone receptor gene. Biology of Reproduction 53:899–904.
   PubMed Web of Science ®Google Scholar
• Tavor O, Shohat M, Lipitz S. 2007. The relationship between perinatal outcome of singleton pregnancies and isolated highly elevated levels of maternal serum human chorionic gonadotropin at mid-gestation. Israel Medical Association Journal 9:509–512.
   PubMed Web of Science ®Google Scholar
• Tovanabutra S, Illingworth PJ, Ledger WL, Glasier AF, Baird DT. 1993. The relationship between peripheral immunoactive inhibin, human chorionic gonadotropin, oestradiol and progesterone during human pregnancy. Clinical Endocrinology 38:101–107.
   PubMed Web of Science ®Google Scholar
• Wald NJ, Densem JW, George L, Muttukrishna S, Knight PG. 1996. Prenatal screening for Down's syndrome using inhibin-A as a serum marker. Prenatal Diagnosis 16:143–153.
   PubMed Web of Science ®Google Scholar
• Yaron Y, Cherry M, Kramer RL, O’Brien JE, Hallak M, Johnson MP, Evans MI. 1999. Second-trimester maternal serum marker screening: maternal serum alpha–fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome. American Journal of Obstetrics and Gynecology 181:968–974.
   PubMed Web of Science ®Google Scholar
• Yuan W, Chen L, Bernal AL. 2009. Is elevated serum alpha-fetoprotein in the second trimester of pregnancy associated with increased preterm birth risk? A systematic review and meta-analysis. European Journal of Obstetrics, Gynecology, and Reproductive Biology 145:57–64.
   PubMed Web of Science ®Google Scholar